UNSPSC 51451803: Nitrodan

This classification denotes an antihelminthic agent with the molecular formula C10H8N4O3S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2STG09LA8F, chemically known as rhodanine, 3-methyl-5-(p-nitrophenylazo)- but generally known as nitrodan, which bears US NIH Compound Identifier 13752. European Medicines Agency schedules Nitrodan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09324MIG. The term NITRODAN is an International Non-Proprietary Name.

UNSPSC 51451803 Nitrodan is a Commodity code under which state and local governments procure naloxone, pharmaceutical products, and medical-emergency supplies for public health, emergency response, and institutional healthcare programs. Recent solicitations show purchasing bodies acquiring naloxone and drug deactivation systems for community health initiatives, generic pharmaceuticals and over-the-counter products through multistate cooperative agreements, and medical and first aid supplies for emergency services divisions. The issuing bodies span county health departments, state health and human services agencies, municipalities, and cooperative purchasing alliances serving multiple jurisdictions. Work ranges from direct procurement of finished pharmaceutical products and emergency medical consumables to vendor capability assessments for direct-to-manufacturer prescription programs and wholesaler-distributed generic pharmaceutical supply chains.

Activity concentrates in Florida, Texas, and Minnesota, with multistate cooperative purchasing vehicles extending coverage to additional states including Oregon. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, through its e-Procurement Portal, with an estimated contract value subject to fixed-fee pricing. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for implementing a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. The City of Tampa released IFB 26P00145 on March 25, 2026, for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with a response deadline of March 13, 2026, an estimated contract amount of $700,000.00, and a small local business enterprise set-aside with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 on January 20, 2026, to establish contracts for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, with proposals due March 26, 2026, and contract effectiveness July 1, 2026.